PharmaCyte Biotech Stock Forecast for 2023 - 2025 - 2030

PharmaCyte Biotech Stock Forecast and Price Target

According to esteemed experts, the average price target for PharmaCyte Biotech to reach this year is $0.00, with a potential downside of approximately 0. This prediction is based on a high estimate of $0.00 and a low estimate of $0.00. If you're considering investing in PMCB stock, it's important to look at its competitors too.